Form 10 Explorer
10-Q
Quarterly Report
BIOMERICA, INC.

BMRA

NASDAQ

CIK: 73290

File #: 001-37863

Period End: Nov 30, 2024

Fiscal Year: 2025

View on EDGAR
Balance Sheet
35 line items · 2 periods
XBRL
ItemNov 30, 2024May 31, 2024
Assets
Current Assets:
Cash and Cash Equivalents
2,372,0004,170,000
Accounts Receivable
1,326,000947,000
Inventory
1,789,0002,376,000
Other Non-Operating Current Assets
458,000238,000
Total current assets
5,945,0007,731,000
Property, Plant and Equipment
167,000201,000
MEXICO
12,00014,000
Operating Lease Right-of-Use Asset
588,000742,000
Cash and Cash Equivalents
165,000165,000
Polish Distributor
165,000—
Intangible Assets
236,000212,000
Other Non-Operating Non-Current Assets
173,000203,000
Total Assets
7,274,0009,254,000
Liabilities and Shareholders’ Equity
Current Liabilities:
Accounts Payable
848,0001,138,000
Other Current Liabilities
601,000655,000
Other Current Liabilities
85,00085,000
Operating Lease Liability, Current
342,000326,000
Total current liabilities
1,876,0002,204,000
Operating Lease Liability, Non-Current
284,000459,000
Total Liabilities
2,160,0002,663,000
Shareholders’ Equity:
Total Stockholders' Equity
1,467,0001,346,000
Total Stockholders' Equity
54,220,00053,542,000
Total Stockholders' Equity
(112,000)(102,000)
Total Stockholders' Equity
(50,461,000)(48,195,000)
Total Shareholders’ Equity
5,114,0006,591,000
Common Stock
1,467,0001,346,000
Additional Paid-in Capital
54,220,00053,542,000
AOCI Attributable to Parent
(112,000)(102,000)
Retained Earnings
(50,461,000)(48,195,000)
Total Liabilities and Shareholders’ Equity
7,274,0009,254,000